Variant position: 37 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1218 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LLALLCALRAKVCGASGQFE LEILSMQNVNGELQNGNCCGG
Mouse LLALLCALRAKVCGASGQFE LEILSMQNVNGELQNGNCCGG
Rat LLALLCALRAKVCGASGQFE LEILSMQNVNGELQNGNCCGG
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
34 – 1218 Protein jagged-1
34 – 1067 Extracellular
1 – 159 Missing. In isoform 2.
33 – 43
Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome.
Morrissette J.J.D.; Colliton R.P.; Spinner N.B.;
Hum. Mol. Genet. 10:405-413(2001)
Cited for: VARIANT ALGS1 SER-37;
Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients.
Colliton R.P.; Bason L.; Lu F.-M.; Piccoli D.A.; Krantz I.D.; Spinner N.B.;
Hum. Mutat. 17:151-152(2001)
Cited for: VARIANTS ALGS1 ASP-33; SER-37; SER-78; ASN-181; TYR-714 AND SER-902;
Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.
Bauer R.C.; Laney A.O.; Smith R.; Gerfen J.; Morrissette J.J.; Woyciechowski S.; Garbarini J.; Loomes K.M.; Krantz I.D.; Urban Z.; Gelb B.D.; Goldmuntz E.; Spinner N.B.;
Hum. Mutat. 31:594-601(2010)
Cited for: VARIANTS SER-664; GLN-937 AND GLN-1104; CHARACTERIZATION OF VARIANTS SER-664 AND GLN-937; VARIANT TOF LEU-810; CHARACTERIZATION OF VARIANTS TOF ASP-274 AND LEU-810; CHARACTERIZATION OF VARIANT ALGS1 SER-37; CHARACTERIZATION OF VARIANT DCHE TYR-234; FUNCTION;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.